← brief for 2026-10-08 · Nutrition & lifestyle

Translational PBPK Modeling and Exposure-Response Analysis of AT-RvD1 for Treating Sjögren's Disease.

Article D Peer reviewed Preclinical

Key takeaways

This study used computer models and mice to look at a medicine for Sjögren's disease. It is not a study in people yet. The goal is to figure out the right dose for humans. This is an early step in drug development.

Who did this work

Yellepeddi VK · Nam K · Maslow FM · Baker OJ

Source

Article · PubMed, Nutritional supplements and CKD · 2026 Oct
https://pubmed.ncbi.nlm.nih.gov/42847668/